Biotech

All Articles

MBX pursues $136M IPO to take competitor to Ascendis right into phase 3

.MBX has actually expanded programs to consume over $136 million from its own IPO as the biotech see...

Relay breast cancer cells data tee up clash with AstraZeneca's Truqap

.Relay Therapeutics has actually beaten its survival target in a first-in-human boob cancer study, s...

AZ details AI-enabled TROP2 biomarker approach for Daiichi ADC

.AstraZeneca has actually used expert system to design an one-of-a-kind biomarker for its own Daiich...

AstraZeneca IL-33 medication stops working to improve COPD breathing in ph. 2

.AstraZeneca execs state they are "not concerned" that the breakdown of tozorakimab in a stage 2 chr...

BMS vet solutions Foghorn's call for CBO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of significant management hirings, shootings ...

Zenas, Bicara laid out to bring up $180M-plus in separate IPOs

.After exposing strategies to reach the USA social markets lower than a month ago, Zenas Biopharma a...

Psyence acquires fellow psilocybin biotech Telepathic

.Psyence Biomedical is actually spending $500,000 in reveals to acquire fellow psilocybin-based biot...

FDA interested Iterum's urinary system system infection medicine might induce antimicrobial resistance

.5 months after signing off on Electrical Rehabs' Pivya as the first brand new treatment for easy ur...

Eli Lilly jumps deeper right into AI with $409M Hereditary Surge package

.Eli Lilly has actually risen into an AI-enabled medicine invention deal, partnering with RNA specia...

After FDA rejection and also discharges, Lykos CEO is leaving behind

.Lykos chief executive officer and owner Amy Emerson is leaving, along with principal functioning of...